A19-144, A2-73 and certain anticholinesterase inhibitor compositions and method for anti-seizure therapy
US10813907B2 · kind B2 · utility
3Cited by
0References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 14, 2019 |
| Grant date | Oct 27, 2020 |
| Priority date | — |
| Expiry date | Oct 14, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D307/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention concerns a dosage form comprising a therapeutically effective amount of A19-144 or A2-73 and a therapeutically effective amount of at least one AED. This invention further encompasses a method of treating a subject in need of such treatment comprising administering a therapeutically effective amount of A19-144 or A2-73 in conjunction with an therapeutically effective amount of an AED.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.